Rothschild & Co Asset Management US’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-156,920
Closed -$3.11M 347
2014
Q4
$3.11M Sell
156,920
-1,312
-0.8% -$29.3K 0.06% 298
2014
Q3
$3.15M Sell
158,232
-41,175
-21% -$867K 0.07% 297
2014
Q2
$4.54M Sell
199,407
-100
-0.1% -$1.78K 0.09% 281
2014
Q1
$2.57M Buy
199,507
+42,327
+27% +$607K 0.06% 324
2013
Q4
$2.14M Buy
157,180
+58,923
+60% +$703K 0.05% 336
2013
Q3
$1.09M Buy
+98,257
New +$978K 0.02% 347

Other funds holding RGEN

Rothschild & Co Asset Management US's RGEN Position: Q1 2015 in Review

Rothschild & Co Asset Management US sold out of Repligen (RGEN) in Q1 2015, closing a stake of 156,920 shares — an estimated $3.11M sold.

Rothschild & Co Asset Management US first reported a position in RGEN in Q3 2013 and held it in 6 quarters. The position peaked at $4.54M in Q2 2014. 168 funds tracked by Wall St. Rank hold RGEN as of Q1 2015.

  • Rothschild & Co Asset Management US reported no remaining Repligen position as of Q1 2015 after selling out during the quarter.
  • Rothschild & Co Asset Management US sold 156,920 Repligen shares in Q1 2015, an estimated $3.11M.
  • Rothschild & Co Asset Management US first reported a position in Repligen in Q3 2013 and held it in 6 quarters.
  • Rothschild & Co Asset Management US's Repligen position peaked at $4.54M in Q2 2014.
  • 168 funds tracked by Wall St. Rank held Repligen as of Q1 2015.

Based on Rothschild & Co Asset Management US's 13F filing for Q1 2015, filed 15 May 2015.